Chiron pharma research
Executive Summary
Pharmacia VP-Discovery Oncology Kenneth Bair, MD, joins Chiron as senior VP-BioPharma research head, effective July 1. He will oversee chemistry, biology, applied biochemistry and discovery projects, and "work with the research head of Chiron's Vaccines and Blood Testing business units to promote organizational synergies," Chiron says. Chiron acquired the vaccine manufacturer Powderject in May (1"The Pink Sheet" May 26, 2003, p. 17). Invenux CEO Carl Pelzel joins Chiron as VP-BioPharma commercial operations...